Patient Safety Movement Announces 69,519 Lives Saved
The Patient Safety Movement Foundation (PSMF) announced today, at the 5th Annual Patient Safety, Science & Technology Summit, that 69,519 lives were saved in 2016, thanks to the efforts of more than 3526 hospitals committing to patient safety and the 70 healthcare technology companies who have signed an open data pledge.
During his keynote address on the first day of the Summit, former Vice President Joe Biden noted the importance of being “unwilling to postpone” the fight to achieve zero preventable deaths by 2020. As he stated, “We cannot spend billions on sublime new therapies to save lives from cancer, only to lose them tragically as a consequence of predictable mistakes.”
Joe Kiani, Founder of the Patient Safety Movement, spoke of the progress made during 2016: “By January 2016 we announced 24,643 lives were saved, and we made the goal to reach 50,000 lives saved by this year. As of February 2017, we've more than doubled that number.”
During today’s proceedings, there was an exclusive screening of the documentary Clean Hands. Clean Hands tells the story of Professor Didier Pittet’s 20-year campaign to promote hand hygiene as a means of preventing nosocomial infections, which are estimated to kill 16 million people worldwide each year. Professor Pittet is an ambassador to the World Health Organization and a speaker at this year’s Summit.
Also taking place today was a panel discussion on the first of three new Actionable Patient Safety Solutions (APSS) introduced at this year’s event, regarding venous thromboembolism (VTE). The Centers for Disease Control (CDC) estimates that as many as 70% of hospital-acquired cases of VTE are preventable, making the need for hospitals to improve awareness and develop new processes acute. The panel, moderated by Mike Durkin, the British National Health Service’s Director of Patient Safety, discussed the challenges surrounding VTE prevention.
Honored at the first day of the Summit were those who have made the greatest contributions in 2016 toward achieving the PSMF’s goal of zero preventable patient deaths by 2020. The 2016 Humanitarian Awards recognized the lifesaving achievements of the following leaders in patient safety:
Patrick H. Conway, MD, MSc
As the Centers for Medicare and Medicaid Services (CMS) Acting Principal Deputy Administrator and Chief Medical Officer, Dr. Conway oversees vital programs that serve the more than 130 million Americans who receive health care services through Medicare, Medicaid, the Children’s Health Insurance Program, and the Health Insurance Marketplace. He and his team work to improve quality, affordability, access, and health outcomes. In 2014, Dr. Conway was elected to the National Academy of Medicine Institute of Medicine (IOM), one of the highest honors in the fields of health and medicine. Dr. Conway, in receiving the award said, "I am honored and humbled to receive the patient safety movement humanitarian award. I look forward to continuing to help improve patient safety across the nation."
Dr. Dave Mayer, MD
Dr. Mayer is Vice President of Quality and Safety for MedStar Health, the largest healthcare provider in the mid-Atlantic region. He oversees the infrastructure for clinical quality and its operational efficiency and designs, and directs system-wide activity for patient safety and risk-reduction programs. Under Mayer, MedStar has been at the vanguard of embracing transparency in communications with patients and families when something goes wrong in treatment. Recently, MedStar worked with the US Agency for Healthcare Research and Quality (AHRQ) to develop and pilot a toolkit for their Communication and Optimal Resolution (CANDOR) program. In receiving the award, Dr. Mayer said, “It’s an amazing honor to be recognized by Joe Kiani and the Patient Safety Movement, to be honored with other recipients who have worked so hard to reduce medical harm. I am humbled to be included with such a wonderful group.”
Ms. Saarinen is the CEO of the Newborn Foundation. She has been recognized by the Patient Safety Movement for spearheading the national effort to ensure all newborns are screened for the most prevalent birth defect, critical congenital heart disease (CCHD), which afflicts one in every 100 newborns. The Newborn Foundation is the first national organization focused on leveraging health, medtech, and biotechnology to improve outcomes and reduce disparities specifically for newborns. Through her work, 99% of babies are now screened for CCHD in the US every year. In receiving the award, Ms. Saarinen noted, “I am surprised and humbled to receive the Humanitarian award from the Patient Safety Movement Foundation. I am grateful for the work Dr. Granelli has done in heart disease which has created a strong platform for the Newborn Foundation to help improve and save the lives of babies. It has been an incredible opportunity to work with the Patient Safety Movement and the other advocates toward this end.”
Dr. Anne de-Wahl Granelli, PhD, MBA
Dr. Granelli has spent the last decade researching CCHD screening and it is because of her work that organizations like Annamarie Saarinen's, the Newborn Foundation, have been able to successfully create policies across the US and the world to ensure that babies don’t leave the hospital without being screened. Dr. Granelli received the award in conjunction with Annamarie to show the great work that has been accomplished in 2016 through continued research. Dr. Granelli said, “I am so honored to be a recipient of the Humanitarian award. It is truly amazing. It has also been a privilege to work with Annamarie Saarinen, and to have such an impact on the lives of babies with critical congenital heart disease.”
About the Patient Safety Movement Foundation
More than 200,000 people die every year in U.S. hospitals and 3 million worldwide in ways that could have been prevented. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare, to reduce that number of preventable deaths to 0 by 2020 (0X2020). Improving patient safety will require a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The Patient Safety Movement Foundation works with all stakeholders to address the problems and solutions of patient safety. The Foundation also convenes Patient Safety, Science and Technology summits. The Summits bring together some of the world’s best minds for thought-provoking discussions and new ideas to challenge the status quo. By presenting specific, high-impact recipes to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data for whom their products are purchased, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, Patient Safety Movement is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.
@0X2020 #patientsafety #0X2020
Patient Safety Movement Foundation
Irene Paigah, 858-859-7001
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
San Francisco 49ers and IDEMIA Announce Strategic Partnership to Enhance Fan Experience23.10.2017 09:30 | Pressemelding
The San Francisco 49ers and IDEMIA announced a new multi-year partnership to promote and implement identity and security services from IDEMIA’S IdentoGO solution, the country’s preeminent identity-related service provider and exclusive provider of TSA Pre✓®, at Levi’s® Stadium. In addition to offering TSA Pre✓® enrollment opportunities at 49ers home games, IDEMIA will equip the stadium with biometric-based technology to assist in fan experience and security in the near future. “We’re always looking for innovative ways to enhance security at Levi’s ® Stadium and IDEMIA’S IdentoGO technology complements our efforts as we strive to provide expedited entry for pre-approved customers,” said Jim Mercurio, 49ers Vice President of stadium operations and Levi’s® Stadium general manager. “We look forward to working with IDEMIA to jointly deploy the first-ever Trusted Fan Progr
E Ink and LTS Partner to Develop Smart Patch to Improve Medical Management23.10.2017 07:00 | Pressemelding
E Ink Holdings, "E Ink" (8069.TW), the leading innovator of electronic ink technology and LTS Lohmann-Therapie Systeme AG, “LTS” leading in the development and manufacturing of transdermal therapeutic systems, today announced their partnership to develop a “Smart Patch” prototype. The Smart Patch prototype is a transdermal therapeutic system (TTS) that delivers medication to patients in a convenient, controlled and comfortable manner and features an E Ink display to deliver and convey relevant information about patch performance. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171023005449/en/ The “Smart Patch” prototype features an E Ink display to convey relevant information about patch performance to patients. (Photo: E Ink Holdings) According to a report conducted by the New England Healthcare Institute
MaxLinear and Corinex to Use G.hn for Open Smart Metering Solution23.10.2017 06:00 | Pressemelding
MaxLinear, Inc. (NYSE:MXL), a leading provider of radio frequency (RF), analog and mixed-signal integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multimarket applications and Corinex, a unique supplier of broadband solutions (BPL) for smart metering and smart grid infrastructure improving grid operational efficiency, security and integration of renewable energy and EV’s today announced that they will cooperate to create a broadband utility infrastructure solution based on standard ITU-T G.hn technology to enable smart metering and other smart grid applications. The G.hn solution will address the growing interest of electricity utilities in leveraging broadband powerline networks for Smart Grid applications, while ensuring multi-vendor interoperability, openness and easy integration into a wide range of Smart Meters and Smart Grid infrastr
NTT Communications to Share Industry Views with Global Carrier Community at Capacity Europe 2017 in London23.10.2017 06:00 | Pressemelding
Executives from NTT Communications (NTT Com), the global data and IP services arm of Fortune Global 500 telecom leader NTT (TYO: 9432), will play a prominent speaking role at this year’s Capacity Europe conference in London – Europe’s largest annual meeting for the global carrier community. During the conference, which runs October 24-26 at the Intercontinental London 02, NTT Com executives will participate in three panels that provide expert analysis and perspective on trending industry topics including the Internet of Things (IoT), network security and the importance of innovation and leadership. NTT Com is in a unique position to address global wholesale trends and opportunities as the global carrier consistently ranks as one of the top IP network providers worldwide. “Coming together as an industry to share insights and perspective is not only beneficia
ADC Therapeutics Announces Closing of $200 Million Private Financing to Fund Two Lead Programs Through Registrational Trials23.10.2017 04:55 | Pressemelding
ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced that it has raised $200 million through a private placement. The financing was oversubscribed and supported by both existing and new investors, including Auven Therapeutics, Redmile, the Wild Family Office and AstraZeneca. The proceeds will be used to progress ADCT-301 and ADCT-402 into planned registrational trials in 2018. Both candidates are currently in four clinical studies in important sub-types of lymphoma and leukemia. ADCT will also advance ADCT-301 into a combination study for solid tumors. Further it will allow the Company to continue the development of the Phase I study of ADCT-502 in patients with advanced solid tumors with HER2 expression, to file INDs for ADCT-602 and ADCT-6
Mitsui Chemicals Tohcello, Inc. Establishes a New Company in Taiwan23.10.2017 02:00 | Pressemelding
Mitsui Chemicals, Inc. (Head Office: Minato-ku, Tokyo; President & CEO: Tsutomu Tannowa) announced that its wholly owned subsidiary, Mitsui Chemicals Tohcello, Inc. (Head Office: Chiyoda-ku, Tokyo; President & CEO: Yoshihisa Fujimaki) has decided to establish a company in Taiwan that will manufacture and sell the ICROS™Tape, a tape for semiconductor manufacturing. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171022005001/en/ ICROS(TM)Tape (Photo: Business Wire) The ICROS™Tape is a protective tape used for semiconductor manufacturing. It holds the world’s largest market share as a protective tape for the back grinding process of silicon wafer. The semiconductor market is experiencing growing demand attributable in part to the growth of mobile terminals. Demand is expected to continue to grow a
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom